Is it safe for a woman with ocular (eye) migraines to take combination birth control that contains estrogen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No, combination birth control is contraindicated in women with ocular migraines (migraine with aura)

Combined hormonal contraceptives containing estrogen are absolutely contraindicated in women with migraine with aura, including ocular migraines, due to a significantly elevated risk of ischemic stroke. 1

Understanding the Stroke Risk

The combination of migraine with aura and estrogen-containing contraceptives creates a multiplicative stroke risk:

  • Migraine with aura alone increases ischemic stroke risk 2.5-fold (RR 2.51; 95% CI 1.52-4.14) 1
  • Estrogen-containing contraceptives alone increase stroke risk approximately 2-fold (RR 1.6-1.7) 1
  • When combined, the risk increases 7-fold (RR 7.02; 95% CI 1.51-32.68) compared to women without migraine who don't use contraceptives 1, 2
  • Women with migraine with aura taking estrogen contraceptives have odds ratios ranging from 2.08 to 16.9 for ischemic stroke 1

Additional Risk Factors That Worsen the Situation

If you have any of these additional risk factors, the stroke risk becomes even more dangerous:

  • Smoking creates catastrophic risk (RR 9.03; 95% CI 4.22-19.34) when combined with migraine and estrogen 1, 2
  • Age over 35 years significantly amplifies risk (RR 3.65; 95% CI 2.21-6.04 for women under 45) 1, 2
  • Hypertension increases myocardial infarction risk 6-68 fold and ischemic stroke risk 3.1-14.5 fold in women taking combined contraceptives 1
  • High migraine frequency (more than weekly attacks) further increases stroke risk (HR 4.25; 95% CI 1.36-13.29) 1, 2

Safe Contraceptive Alternatives

Progestogen-only methods are the recommended alternative because they do not carry the same stroke risk as estrogen-containing contraceptives:

  • Progestogen-only pills show no increased risk of myocardial infarction (RR 0.98; 95% CI 0.66-1.47) or stroke (RR 1.02; 95% CI 0.72-1.44) 1
  • Desogestrel 75μg progestogen-only pill may actually reduce migraine frequency and intensity in both migraine with and without aura 3
  • Other progestogen-only options include implants, injectables (DMPA), and levonorgestrel IUDs, all of which are safe in migraine with aura 1, 3
  • Barrier methods (condoms, diaphragm) carry no stroke risk and are classified as Category 1 (no restrictions) 1

Critical Clinical Pitfalls to Avoid

  • Do not assume "ocular migraine" means migraine without aura - ocular migraines typically involve visual aura symptoms (flashing lights, zigzag lines, temporary vision loss) and should be treated as migraine with aura 1
  • Do not prescribe combined contraceptives even if aura symptoms seem "mild" - the guideline contraindication applies regardless of aura severity 1
  • Do not continue combined contraceptives if new aura symptoms develop - women with migraine without aura who develop aura while taking combined contraceptives must discontinue them immediately 4, 5
  • Do not rely on lower-dose estrogen formulations as "safer" - even formulations with <50μg estrogen carry increased stroke risk in migraine with aura 1, 4, 6

What If Combined Contraceptives Are Already Being Used?

Stop the combined hormonal contraceptive immediately and transition to a progestogen-only method 1. The absolute contraindication applies regardless of how long the medication has been used without problems - stroke risk remains elevated throughout use 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gender-Affirming Estrogen Therapy in Migraine with Aura

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral contraceptives in migraine.

Expert review of neurotherapeutics, 2009

Related Questions

What is the recommended treatment for a female patient of childbearing age with migraine with aura, considering the use of Provera (medroxyprogesterone acetate)?
Is Yasmin (drospirenone and ethinyl estradiol) safe for a 36-year-old female with migraines with aura?
What birth control options are safe for women with migraines?
What contraceptive options are safe for women with migraines, especially those with aura?
What is the relationship between the combined oral contraceptive (COC) pill and migraine headaches?
What is the comparison between paliperidone (Invega) and clozapine for an adult patient with treatment-resistant schizophrenia who has failed at least two other antipsychotic medications?
What is the first line treatment for plantar wart removal?
How to measure urine osmolality in an elderly patient with suspected hyponatremia at a hospital?
What is the most effective method for managing postoperative pain in a postpartum woman who has undergone a cesarean section (C-section)?
What is the likelihood of pneumocystosis (PCP) in a 40-year-old HIV-positive patient with recent diagnosis, presenting with pneumonia, interstitial radiographic pattern, elevated inflammatory markers, leukocytosis, and lymphopenia, with a potential CD4 count above 300 cells/μL and a lymphocyte count of 1.74 x 10^9/L?
What is the significance of an elevated Brain Natriuretic Peptide (BNP) in the 600's in a patient with a Left Ventricular Ejection Fraction (LVEF) of 55% and potential cardiovascular risk factors or existing heart disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.